ITOVEBI Trademark
ITOVEBI is a USPTO trademark filed by Genentech, Inc.. Status: Registered.
Prosecution Summary
Trademark Summary
ITOVEBI is a standard character mark owned by Genentech, Inc., a Delaware corporation based in South San Francisco, California. It covers pharmaceutical preparations for use in oncology in International Class 005, along with classes 006, 018, 044, 046, 051, and 052. The mark is registered on the Principal Register, with registration number 7875735 issued on July 29, 2025. No active oppositions or legal proceedings are present.
Recent Activity
The application was filed on July 15, 2024, as an intent-to-use basis, advanced through a non-final office action in August 2024 and response in October 2024, and was published for opposition on November 26, 2024. A statement of use was filed on February 10, 2025, accepted in July 2025, leadin
Trademark Facts
| Mark | ITOVEBI |
|---|---|
| Serial Number | 98648555 |
| Registration Number | 7875735 |
| Status | Registered |
| Filing Date | 2024-07-15 |
| Registration Date | 2025-07-29 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Genentech, Inc. |
| Attorney of Record | Gregory Zinkl |
| Prosecution Events | 29 |
| Latest Event | EWAF on 2026-04-09 |
Goods & Services
Pharmaceutical preparations for use in oncology